Arundhati Parmar
Omar Ishrak spoke with MD+DI in a wide-ranging interview in August, where the chief executive of the second-largest device firm in the world spoke about innovation, the hospital services business, risk-based purchasing contracts and much more.
That Ishrak was firmly behind accountable care became very clear during the course of the interview. But notably he also tied the notion of accountability solidly to the future of medtech and the biggest threat and opportunity in the industry faces.